« Previous
Next »
Journal of Critical Care
Volume 27, Issue 2
, Pages 218.e9-218.e20
, April 2012
Feasibility of continuous multiorgan variability analysis in the intensive care unit
To access this article, please choose from the options below
☆ Institution at which the work was done: Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
☆☆ Competing interests: Andrew JE Seely founded Therapeutic Monitoring Systems (TMS), Inc. to commercialize patented Continuous Individualized Multiorgan Variability Analysis (CIMVA) technology with the objective of delivering variability-directed clinical decision support to improve quality and efficiency of care. All the other authors have no conflicts of interest to disclose.
PII: S0883-9441(11)00442-4
doi: 10.1016/j.jcrc.2011.09.009
© 2012 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Critical Care
Volume 27, Issue 2
, Pages 218.e9-218.e20
, April 2012
